GO:1902475 L-alpha-amino acid transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902475 describes the directed movement of L-alpha-amino acids across a membrane via transporters or pores.
• Transport can be sodium-stimulated, as shown in rabbit kidney brush border vesicles.
• Membrane transport is a target for antimicrobials such as pyrithione, which disrupts transport and ATP levels.
• The K+ amino acid transporter KAAT1 and its mutant Y147F demonstrate altered transport activity and substrate selectivity.
• Studying this process requires membrane vesicle assays, electrophysiology, and CRISPR-based genetic models.
• Dysregulation of amino acid transport is linked to metabolic and renal disorders, making it a research priority.
Description
L-alpha-amino acid transmembrane transport (GO:1902475) is a fundamental biological process that mediates the movement of L-alpha-amino acids across cellular membranes. This process is essential for nutrient uptake, protein synthesis, and metabolic homeostasis in all organisms. The directed transport of amino acids is achieved by specialized membrane proteins, including transporters and channels, which ensure the selective passage of these building blocks. Understanding the molecular mechanisms of this transport is critical for deciphering how cells respond to nutritional and environmental cues. Research has shown that transport activity can be modulated by ions such as sodium, as demonstrated in kidney brush border vesicles where sodium-stimulated pathways were delineated. Moreover, amino acid transporters are targets for antimicrobial agents; pyrithione, for example, disrupts membrane transport and ATP levels, highlighting the vulnerability of these systems. The K+ amino acid transporter KAAT1 and its mutant Y147F further illustrate how single amino acid changes can alter transport activity and substrate selectivity, providing insights into structure-function relationships. Given the broad physiological importance, GO:1902475 is a key area of study for cell biologists, biochemists, and drug discovery researchers.
L-alpha-amino acid transmembrane transport At A Glance
| GO ID | GO:1902475 |
|---|---|
| GO term | L-alpha-amino acid transmembrane transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Directed movement of L-alpha-amino acids across membranes |
| Cellular location | Plasma membrane, organelle membranes |
| Transporters involved | Amino acid transporters, ion-coupled symporters, channels |
| Regulation | Ion gradients, substrate availability, hormonal signals |
What Is GO:1902475?
GO:1902475 is defined as the directed movement of L-alpha-amino acid across a membrane by means of some agent such as a transporter or a pore. This process encompasses the translocation of L-enantiomers of amino acids, which are the biologically active forms used in protein synthesis. It requires a membrane-spanning machinery, often driven by ion gradients or ATP, and is distinct from passive diffusion. The term is a biological process and does not include the transport of D-amino acids or small peptides.
Why Is L-alpha-amino acid transmembrane transport Important in Cell Biology?
L-alpha-amino acid transmembrane transport is vital for maintaining cellular amino acid pools, which are required for protein synthesis, energy metabolism, and signaling. Defects in this process can lead to metabolic disorders, renal dysfunction, and increased susceptibility to pathogens. The transport machinery is also a target for antimicrobials and chemotherapeutics, underscoring its clinical relevance. Moreover, studying this process provides insights into membrane protein structure-function relationships, as exemplified by the KAAT1 mutant Y147F.
• Essential for nutrient uptake and protein synthesis in all cells.
• Sodium-stimulated transport pathways are critical for renal amino acid reabsorption.
• Disruption of transport by antimicrobials like pyrithione affects ATP levels and protein synthesis.
• Mutations in transporters can alter substrate selectivity and transport activity.
• Amino acid transport is linked to metabolic reprogramming in cancer.
• Transporters are potential drug targets for infectious diseases.
• Understanding transport mechanisms aids in designing transporter-specific therapies.
• Genetic models of transporters help dissect their physiological roles.
What Happens During L-alpha-amino acid transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter first grabs the amino acid it wants to move.
Transporters exhibit specificity for L-alpha-amino acids, often discriminating against D-isomers. The binding site recognizes the amino acid's alpha-carboxyl and alpha-amino groups, as well as the side chain. In the K+ amino acid transporter KAAT1, mutation Y147F alters substrate selectivity, indicating that specific residues govern recognition.
Conformational Changes and Translocation
In simple terms: The transporter changes shape to carry the amino acid across the membrane.
Upon substrate binding, transporters undergo conformational changes that move the amino acid from one side of the membrane to the other. This process can be coupled to ion gradients, such as sodium, as seen in kidney brush border vesicles where sodium-stimulated transport pathways were delineated. The energy for this movement often comes from the electrochemical gradient of the driving ion.
Ion Coupling and Driving Forces
In simple terms: Ions like sodium help push the amino acid into the cell.
Many amino acid transporters are symporters that couple the movement of L-alpha-amino acids to the inward flux of sodium or potassium ions. In rabbit kidney brush border vesicles, sodium-stimulated amino acid transport pathways were identified, highlighting the role of sodium gradients in driving uptake. The K+ amino acid transporter KAAT1 uses potassium as a driving ion, and its mutant Y147F shows increased transport activity, suggesting altered ion coupling.
Regulation and Inhibition
In simple terms: Transport can be turned up or down by other molecules.
Transport activity is regulated by substrate availability, hormones, and pharmacological agents. Pyrithione, an antimicrobial, disrupts membrane transport, ATP levels, and protein synthesis, demonstrating that transport can be inhibited by small molecules. Such inhibition can lead to cellular stress and growth arrest.
Key Genes Involved in GO:1902475 L-alpha-amino acid transmembrane transport
The following genes and proteins are key players in L-alpha-amino acid transmembrane transport, as evidenced by functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KAAT1 | K+ amino acid transporter | Mutant Y147F shows increased transport activity and altered substrate selectivity |
| SLC6A19 | Sodium-dependent amino acid transporter | Mediates renal amino acid reabsorption; studied in brush border vesicles |
| SLC7A5 | L-type amino acid transporter | Implicated in cancer metabolism and drug delivery |
| SLC1A5 | Alanine, serine, cysteine transporter | Glutamine transport; target in cancer research |
| SLC3A2 | Heavy chain of amino acid transporters | Chaperone for light chains; affects transport activity |
| SLC7A11 | Cystine/glutamate antiporter | Redox balance; ferroptosis regulation |
| SLC38A1 | System A transporter | Glutamine and alanine transport; nutrient sensing |
| SLC38A2 | System A transporter | Neuronal amino acid transport |
| SLC6A14 | Amino acid transporter | Upregulated in cancer; potential drug target |
| SLC16A10 | Aromatic amino acid transporter | Thyroid hormone transport |
| SLC43A1 | L-type amino acid transporter | Branched-chain amino acid transport |
| SLC7A1 | Cationic amino acid transporter | Arginine transport; nitric oxide synthesis |
| SLC7A2 | Cationic amino acid transporter | Arginine and lysine transport |
| SLC25A12 | Mitochondrial aspartate/glutamate carrier | Urea cycle and energy metabolism |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier | Citrin deficiency; aspartate transport |
| SLC1A3 | Glutamate transporter | Neurotransmission; excitotoxicity |
| SLC1A2 | Glutamate transporter | Glutamate clearance in brain |
How Is L-alpha-amino acid transmembrane transport Regulated?
L-alpha-amino acid transmembrane transport is regulated at multiple levels. Transcriptional regulation controls transporter expression in response to nutrient availability and hormones. Post-translational modifications, such as phosphorylation, can modulate transporter activity and trafficking. Ion gradients, particularly sodium and potassium, provide the driving force and are maintained by pumps like Na+/K+-ATPase. Additionally, pharmacological agents such as pyrithione can inhibit transport, affecting ATP levels and protein synthesis. The K+ amino acid transporter KAAT1 mutant Y147F exhibits altered transport activity, suggesting that intrinsic structural features also regulate function.
L-alpha-amino acid transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A19 | Hartnup disorder | Knockout mouse model; renal brush border vesicles |
| SLC7A5 | Cancer proliferation | Overexpression in cancer cell lines; xenograft models |
| SLC1A5 | Glutamine addiction in cancer | CRISPR knockout in cancer cells; metabolomics |
| KAAT1 | Transport activity and selectivity | Point mutation Y147F in Xenopus oocytes |
| SLC7A11 | Ferroptosis and redox balance | Knockout and overexpression models; oxidative stress assays |
Metabolic and Renal Disorders
Dysregulation of amino acid transport can lead to metabolic imbalances and renal dysfunction. Sodium-stimulated amino acid transport pathways in kidney brush border vesicles are critical for reabsorption; defects can cause aminoaciduria. Mutations in transporters like SLC6A19 cause Hartnup disorder, characterized by neutral aminoaciduria.
Cancer Metabolism
Many amino acid transporters are upregulated in cancer to support rapid growth. For example, SLC7A5 and SLC1A5 are overexpressed in various tumors, providing essential amino acids for proliferation. Targeting these transporters is a potential therapeutic strategy.
Infectious Diseases
Amino acid transporters are targets for antimicrobials. Pyrithione disrupts membrane transport, ATP levels, and protein synthesis, demonstrating that interfering with transport can inhibit microbial growth. This highlights the potential of transport inhibitors as antimicrobial agents.
From L-alpha-amino acid transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of transporter knockout on amino acid uptake? | CRISPR knockout cell lines; transport assays |
| How does a point mutation alter substrate selectivity? | Point mutation knock-in (e.g., KAAT1 Y147F) |
| Can a transporter be tagged for localization studies? | Tagged knock-in (e.g., GFP) in cell lines |
| What is the effect of transporter overexpression on metabolism? | Overexpression cell lines; metabolomics |
| How does sodium stimulate transport? | Kidney brush border vesicles; ion gradient assays |
| Can transport inhibitors be identified? | High-throughput screening with fluorescent substrates |
How to Study the L-alpha-amino acid transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Membrane vesicle transport assay | Transport activity and ion dependence | Renal amino acid reabsorption |
| Electrophysiology | Transporter currents and ion coupling | Characterization of KAAT1 mutants |
| CRISPR knockout | Gene function in transport | Identifying essential transporters |
| Overexpression | Gain-of-function effects | Cancer metabolism studies |
| Metabolomics | Intracellular amino acid levels | Metabolic profiling |
| Fluorescent substrate uptake | Transport rate and specificity | High-throughput screening |
| Proteomics | Transporter expression and modifications | Regulation studies |
| RNA-seq | Transcriptional changes in transporters | Nutrient response pathways |
Membrane Vesicle Transport Assays
Membrane vesicles, such as rabbit kidney brush border vesicles, are used to measure sodium-stimulated amino acid transport. This method allows delineation of transport pathways and kinetics.
Electrophysiology
Electrophysiological techniques, such as two-electrode voltage clamp in Xenopus oocytes, measure transporter activity and ion coupling. This approach was used to characterize the KAAT1 mutant Y147F.
CRISPR-Based Genetic Screens
CRISPR knockout or activation screens can identify genes that regulate amino acid transport. Libraries targeting transporters can reveal synthetic lethal interactions.
Metabolomics and Flux Analysis
Metabolomics measures intracellular amino acid levels, while flux analysis traces transport dynamics. These methods are used to study metabolic reprogramming in cancer.
How CRISPR Can Be Used to Study GO:1902475 L-alpha-amino acid transmembrane transport
Knockout
CRISPR knockout of amino acid transporter genes, such as SLC7A5 or SLC1A5, can abolish transport activity, leading to reduced amino acid uptake and altered metabolism. This is used to study the physiological role of specific transporters.
Point Mutation
Point mutations can be introduced to mimic naturally occurring variants or to probe structure-function relationships. For example, the KAAT1 Y147F mutation was studied to understand substrate selectivity and transport activity.
Knock-in
Knock-in of tagged transporters (e.g., GFP) allows visualization of localization and trafficking in live cells. This helps determine how transporters are targeted to the plasma membrane.
Overexpression
Overexpression of transporters can increase amino acid uptake and drive proliferation, as seen in cancer. This model is used to study oncogenic roles and drug resistance.
How EDITGENE Supports L-alpha-amino acid transmembrane transport Research
Researchers studying L-alpha-amino acid transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides CRISPR-based services to create precise genetic models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for L-alpha-amino acid transmembrane transport research.
Frequently Asked Questions About L-alpha-amino acid transmembrane transport
What is L-alpha-amino acid transmembrane transport?
It is the directed movement of L-alpha-amino acids across a membrane by transporters or pores, as defined by GO:1902475.
What genes are involved in L-alpha-amino acid transmembrane transport?
Genes include KAAT1, SLC6A19, SLC7A5, SLC1A5, and many other solute carrier family members.
How is L-alpha-amino acid transport regulated?
It is regulated by ion gradients, hormones, substrate availability, and post-translational modifications.
Why is L-alpha-amino acid transport important for health?
It is essential for nutrient uptake, protein synthesis, and metabolic homeostasis; defects cause diseases like Hartnup disorder.
What diseases are associated with defects in amino acid transport?
Metabolic disorders, renal aminoaciduria, and cancer are linked to transport dysfunction.
How can I study L-alpha-amino acid transport in the lab?
Use membrane vesicle assays, electrophysiology, and CRISPR knockout models.
What is the role of sodium in amino acid transport?
Sodium often provides the driving force for symport, as shown in kidney brush border vesicles.
Can amino acid transporters be targeted by drugs?
Yes, antimicrobials like pyrithione inhibit transport, and cancer drugs target transporters.
What is the KAAT1 Y147F mutant?
It is a point mutant of the K+ amino acid transporter with increased transport activity and altered substrate selectivity.
How does CRISPR help study amino acid transport?
CRISPR enables knockout, point mutation, knock-in, and overexpression models to dissect gene function.
Conclusion
L-alpha-amino acid transmembrane transport (GO:1902475) is a cornerstone of cellular metabolism and physiology. Research using membrane vesicles, electrophysiology, and CRISPR models has revealed key transporters and regulatory mechanisms. Understanding this process opens avenues for therapeutic intervention in metabolic diseases and cancer. EDITGENE provides comprehensive CRISPR services to support these investigations.
References
- 1. Liu Z et al.. 2003. K+ amino acid transporter KAAT1 mutant Y147F has increased transport activity and altered substrate selectivity.. J Exp Biol 206(Pt 2):245-54 PMID: 12477895
- 2. Mircheff AK et al.. 1982. Delineation of sodium-stimulated amino acid transport pathways in rabbit kidney brush border vesicles.. J Membr Biol 64(1-2):113-22 PMID: 7057450
- 3. Chandler CJ et al.. 1978. Mechanism of the antimicrobial action of pyrithione: effects on membrane transport, ATP levels, and protein synthesis.. Antimicrob Agents Chemother 14(1):60-8 PMID: 28693
